http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105486871-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-015 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-558 |
| filingDate | 2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105486871-B |
| titleOfInvention | A kind of quick detection canine parvovirus antibody blood clotting suppresses colloidal gold strip, kit and the detection method of potency |
| abstract | The invention discloses colloidal gold strip, kit and the detection method that a kind of quick detection canine parvovirus antibody blood clotting suppresses potency.The present invention relates to the test strips that CPV therapeutic monoclonal antibodies are prepared from, by dog serum from 1 when quantitatively detecting:10 start doubling dilution, after being neutralized with the CPV standard antigens of 16 antigen units, instill again in this test strips, serum highest extension rate when ELISA test strip line (T lines) disappears is ELISA test strip potency (CGIA potency), and it is antibody HI potency in dog serum that CGIA potency, which is multiplied by 4,；Using 32 antigen units standard antigen when, CGIA potency be multiplied by 8 be HI potency；Using 8 antigen units standard antigen when, CGIA potency be multiplied by 2 be HI potency；Using 4 antigen units standard antigen when, CGIA potency be equal to HI potency.This method and blood clotting blood press down the coincidence rate of detection method result up to 90.7%, and the coincidence rate of antibody qualitative detection result is up to 98.8%, available for CPV vaccine immunity effect evaluations. |
| priorityDate | 2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.